Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ACE2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | ACE2 |
| Key Genes/Proteins | ALDH1A1, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, APOE, APOE4 |
| Related Diseases | Aging, Als, ALS, Alzheimer |
| Related Pathways | Amyloid, Apoptosis |
Knowledge base pages for this entity
graph TD
ACE2["ACE2"]
ACE2 -->|"targets"| SARS_CoV_2["SARS-CoV-2"]
ACE2 -->|"binds_to"| SARS_COV_2["SARS-COV-2"]
ACE2 -->|"targets"| Sars_Cov_2["Sars-Cov-2"]
ACE2 -->|"binds"| Sars_Cov_2_Receptor_Binding_Do["Sars-Cov-2 Receptor Binding Domain"]
ACE2 -->|"participates in"| Counter_regulatory_Renin_Angio["Counter-regulatory Renin-Angiotensin System"]
ACE2 -.protects against.-> Ms["Ms"]
SARS_CoV_2 -->|"binds"| ACE2
FCGRT["FCGRT"] -.protects against.-> ACE2
NEP["NEP"] -->|"activates"| ACE2
APOPTOSIS["APOPTOSIS"] -->|"activates"| ACE2
ALZHEIMER["ALZHEIMER"] -->|"activates"| ACE2
NEPRILYSIN["NEPRILYSIN"] -->|"activates"| ACE2
TAU["TAU"] -->|"activates"| ACE2
NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| ACE2| Target | Relation | Type | Str |
|---|---|---|---|
| Sars-Cov-2 | targets | disease | 0.90 |
| SARS-CoV-2 | binds | entity | 0.90 |
| SARS-COV-2 | binds_to | entity | 0.90 |
| Sars-Cov-2 Receptor Binding Domain | binds | compound | 0.85 |
| Counter-regulatory Renin-Angiotensin System | participates_in | pathway | 0.80 |
| Ang-(1-7) | produces | compound | 0.80 |
| Ang II | converts_to | compound | 0.80 |
| Als | associated_with | disease | 0.65 |
| Diabetes | inhibits | disease | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| Diabetes | causes | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Ms | protects_against | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| ALS | protects_against | disease | 0.65 |
| PDGFA | activates | gene | 0.60 |
| PLAU | activates | gene | 0.60 |
| S100A8 | activates | gene | 0.60 |
| S100A9 | activates | gene | 0.60 |
| TGM2 | activates | gene | 0.60 |
| TMPRSS2 | protects_against | gene | 0.60 |
| FCGRT | protects_against | gene | 0.60 |
| neuroinflammation | associated_with | disease | 0.60 |
| CRISPR-Cas | participates_in | pathway | 0.60 |
| CLU | activates | gene | 0.60 |
| HMGB2 | activates | gene | 0.60 |
| MMP12 | activates | gene | 0.60 |
| TMPRSS2 | interacts_with | gene | 0.60 |
| FCGRT | activates | gene | 0.60 |
| SARS | activates | gene | 0.60 |
| TMPRSS2 | activates | gene | 0.60 |
| FGF21 | regulates | gene | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| FGF21 | activates | gene | 0.60 |
| neurodegeneration | regulates | disease | 0.60 |
| SARS | interacts_with | gene | 0.60 |
| FCGRT | interacts_with | gene | 0.60 |
| NEP | associated_with | gene | 0.60 |
| IDE | expressed_in | gene | 0.60 |
| NEP | expressed_in | gene | 0.60 |
| IDE | activates | gene | 0.60 |
| hippocampus | expressed_in | brain_region | 0.60 |
| Apoptosis | activates | pathway | 0.60 |
| CTSD | associated_with | gene | 0.60 |
| SARS | regulates | gene | 0.60 |
| IDE | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| FGF21 | interacts_with | gene | 0.80 |
| HMOX1 | associated_with | gene | 0.60 |
| FGF21 | associated_with | gene | 0.60 |
| LPL | associated_with | gene | 0.60 |
| ALDH1A1 | associated_with | gene | 0.60 |
| GUSB | associated_with | gene | 0.60 |
| SARS | inhibits | gene | 0.60 |
| NEP | activates | gene | 0.60 |
| AMYLOID | associated_with | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| NEPRILYSIN | activates | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| FCGRT | protects_against | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| APOE | interacts_with | gene | 0.60 |
| ALZHEIMER | interacts_with | gene | 0.60 |
| SARS | interacts_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ACE2 in their description or question text
No additional research found